Today, we are honored to speak with Professor Dr. Frederik Trinkmann, Executive Senior Physician at the Department of Pulmonology and Respiratory Medicine at the Thorax Clinic in Heidelberg. Professor Dr. Trinkmann is a well-recognized clinician and scientist in Respiratory Medicine, Bioinformatics, and digital health integration. He brings deep expertise in respiratory...
Did you know that up to 90 % of inhaler users make critical mistakes that reduce treatment effectiveness? At VisionHealth, we’re leveraging AI to change that. Today, we sit down with Julian Rösch, Product Manager at VisionHealth, to explore how artificial intelligence is revolutionizing inhalation therapy and improving respiratory care. 1. What...
New digital coaching app enhances patient experience and clinician oversight through guided therapy, reminders, and adherence tracking. San Clemente, Calif. May 15, 2025 – ICU Medical Inc. (NASDAQ:ICUI), in collaboration with VisionHealth GmbH, has announced the launch of MyAcapella, a mobile application designed to support Oscillating Positive Expiratory Pressure (OPEP) therapy for patients with...
Did you know that up to 90 % of inhaler users make critical mistakes that reduce treatment effectiveness? At VisionHealth, we’re leveraging AI to change that. Today, we sit down with Budhaditya Mukhopadhyay, an AI authority at VisionHealth, to explore how artificial intelligence is revolutionizing inhalation therapy and improving respiratory care. 1....
In the fast-evolving landscape of digital healthcare, safeguarding sensitive information is not just a regulatory requirement but a cornerstone of trust and operational excellence. At VisionHealth, we are proud to announce the renewal of our ISO 27001 certification. 1. A Robust Framework for Data Security The ISMS certification is more than an...
Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunities Sabine Häussermann transitions to newly created role of Chief Scientific Officer to drive company’s scientific evidence development initiatives Munich (Germany) and Boston, MA USA, February 18, 2025 – VisionHealth GmbH, a pioneer...
VisionHealth raises 3 million Euro to finance extended COPD and asthma study for market preparation of Kata®, an innovative digital therapeutic for improved inhalation DB Speciality Invest, an investment firm of Dr. Dietrich Bruchmann, invests in VisionHealth Funds will be used for EU and U.S. regulatory approval and commercial launch...
Nagarjun Anantha Padmanabha has been part of the VisionHealth team for four years. As Head of Software Development, he has a lot of responsibilities and a varied scope of duties. This includes, but is not limited to, organizing and leading development teams in the creation of software products, planning, scheduling,...
VisionHealth’s Kata® Clinical to be included into Alcedis service platform for clinical studies Kata® Clinical app supports clinical trials in the field of chronic lung diseases and can be customized to each trial’s individual requirements Based on artificial intelligence (AI), Kata® Clinical can improve both study outcomes and participants’ experience Munich...
VisionHealth receives EU Medical Device Regulation certification VisionHealth is among the first app manufacturers to receive EU Medical Device Regulations (MDR) certification MDR certification prerequisite to enhance, further develop and release future Kata® versions Next Kata® app version will be a CE marked class IIa medical device (MDR) Munich (Germany), December...
